Article Text


Licensing of mifepristone in New Zealand and Australia
  1. Margaret Sparrow, FAChSHM, FRANZCOG
  1. Istar Ltd, Wellington, New Zealand; msparrow{at}

Statistics from

The legal opinion article1 by Sam Rowlands in the April 2012 issue of this Journal raises important issues but I would like to correct the statement regarding the licensing of mifepristone in New Zealand and Australia. The two countries have an entirely different history regarding the licensing of mifepristone. In New Zealand in 1999 a group of doctors formed a not-for-profit pharmaceutical company to import mifepristone from France. The drug was approved for use in New Zealand in 2001 and the company, Istar Ltd, has supplied Australian providers since the Australian law change in 2006.


View Abstract


  • Competing interests The author is a Director of Istar Ltd.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.